One of the most common birth defects worldwide is hearing loss. Every 1,000 babies born worldwide are affected by permanent hearing loss in one or both ears. Hearing loss can significantly affect a baby's development.
CapitalBiotech has developed the Hereditary Deafness Gene Detection Assay using semiconductor sequencing technology. It can identify 100 mutant sites on 18 deafness-related genes such as GJB2, SLA26A4, GJB3, MT-RNR1, and others. This detection assay boasts an accuracy of over 99.9%.
The BioElectron Gene Squencer 4000 platform was developed in collaboration with Thermo Fisher. It can detect 384 samples simultaneously.
Applications of Microarray Platforms in Modern Biological ResearchApril 2, 2026Microarray platforms are essential tools in genomics and molecular biology, providing an efficient and high-throughput method for simultaneously measuring the expression of thousands of genes or detec...view
Microbiome Sequencing: The Next Frontier in Personalized MedicineJune 26, 2023In the past few decades, we have witnessed remarkable advancements in medical technology that have revolutionized the way we approach healthcare. One of the most promising frontiers in this field is m...view
Concept and Application of Microarray PlatformsApril 16, 2025Concept of Microarray PlatformsA microarray platform is a high-throughput experimental platform based on miniaturization technology. It can simultaneously detect and analyze multiple biomolecules (suc...view